Morphine sensitization in the pentylenetetrazole-induced clonic seizure threshold in mice: Role of nitric oxide and μ receptors

Epilepsy and Behavior

Volumn 20, Issue 4, 2011, Pages 602-606

  Shafaroodi, Hamed ^a   Baradaran, Nazanin ^b   Moezi, Leila ^c   Dehpour, Siavash ^b   Kabiri, Tina ^b   Dehpour, Ahmad R ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Addiction; Clonic seizure; Mice; Morphine; Nitric oxide; Sensitization

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NALTREXONE; NITRIC OXIDE; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SENSITIZATION; MALE; MOUSE; NONHUMAN; SEIZURE THRESHOLD;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MICE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTYLENETETRAZOLE; RECEPTORS, OPIOID, MU; SEIZURES;

EID: 79954612722     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.12.020     Document Type: Article

References (53)

1. Babbini M., Davis W.M. Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br J Pharmacol 1972, 46:213-224.
2. Spanagel R., Almeida O.F., Shippenberg T.S. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse 1993, 14:243-245.
3. Vanderschuren L.J., Tjon G.H., Nestby P., Mulder A.H., Schoffelmeer A.N., De Vries T.J. Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of the pretreatment regimen. Psychopharmacology (Berl) 1997, 131:115-122.
4. Tjon G.H., De Vries T.J., Ronken E., et al. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation. Eur J Pharmacol 1994, 252:205-212.
5. Kuribara H. Effects of interdose interval on ambulatory sensitization to methamphetamine, cocaine and morphine in mice. Eur J Pharmacol 1996, 316:1-5.
6. Kumar R., Mitchell E., Stolerman I.P. Disturbed patterns of behaviour in morphine tolerant and abstinent rats. Br J Pharmacol 1971, 42:473-484.
7. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 1976, 260:731-732.
8. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
9. Masur J., Oliveira de Souza M.L., Zwicker A.P. The excitatory effect of ethanol: absence in rats, no tolerance and increased sensitivity in mice. Pharmacol Biochem Behav 1986, 24:1225-1228.
10. Ksir C., Hakan R., Hall D.P., Kellar K.J. Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors. Neuropharmacology 1985, 24:527-531.
11. Schoffelmeer A.N., Voorn P., Jonker A.J., et al. Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization. Neurochem Res 1996, 21:1417-1423.
12. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
13. Gaiardi M., Bartoletti M., Bacchi A., Gubellini C., Costa M., Babbini M. Role of repeated exposure to morphine in determining its affective properties: place and taste conditioning studies in rats. Psychopharmacology (Berl) 1991, 103:183-186.
14. Spanagel R. Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 1995, 70:37-49.
15. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995, 38:95-137.
16. Cadoni C., Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 1999, 90:447-455.
17. Vezina P., Kalivas P.W., Stewart J. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res 1987, 417:51-58.
18. Marinelli M., Le Moal M., Piazza P.V. Sensitization to the motor effects of contingent infusions of heroin but not of kappa agonist RU 51599. Psychopharmacology (Berl) 1998, 139:281-285.
19. Vigano D., Rubino T., Di Chiara G., Ascari I., Massi P., Parolaro D. Mu opioid receptor signaling in morphine sensitization. Neuroscience 2003, 117:921-929.
20. Stefano G.B., Cadet P., Fimiani C., Magazine H.I. Morphine stimulates iNOS expression via a rebound from inhibition in human macrophages: nitric oxide involvement. Int J Immunopathol Pharmacol 2001, 14:129-138.
21. Kolesnikov Y.A., Pick C.G., Ciszewska G., Pasternak G.W. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 1993, 90:5162-5166.
22. Kimes A.S., Vaupel D.B., London E.D. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology (Berl) 1993, 112:521-524.
23. Zarrindast M.R., Gholami A., Sahraei H., Haeri-Rohani A. Role of nitric oxide in the acquisition and expression of apomorphine- or morphine-induced locomotor sensitization. Eur J Pharmacol 2003, 482:205-213.
24. Pudiak C.M., Bozarth M.A. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci 1993, 53:1517-1524.
25. Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res 1983, 287:197-210.
26. Lauretti G.R., Ahmad I., Pleuvry B.J. The activity of opioid analgesics in seizure models utilizing N-methyl-DL-aspartic acid, kainic acid, bicuculline and pentylenetetrazole. Neuropharmacology 1994, 33:155-160.
27. Homayoun H., Khavandgar S., Namiranian K., Gaskari S.A., Dehpour A.R. The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res 2002, 48:33-41.
28. Frey H.H. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266. Pharmacol Toxicol 1988, 62:150-154.
29. Khavandgar S., Homayoun H., Dehpour A.R. Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice. Pharmacol Biochem Behav 2003, 74:795-801.
30. Shavit Y., Caldecott-Hazard S., Liebeskind J.C. Activating endogenous opioid systems by electroconvulsive shock or footshock stress inhibits recurrent kindled seizures in rats. Brain Res 1984, 305:203-207.
31. Berman E.F., Adler M.W. The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats. Neuropharmacology 1984, 23:367-371.
32. Votava M., Krsiak M., Moravec V. Effects of alprazolam and fluoxetine on morphine sensitization in mice. Physiol Res 2002, 51:417-423.
33. Swinyard E.A., Kupferberg H.J. Antiepileptic drugs: detection, quantification, and evaluation. Fed Proc 1985, 44:2629-2633.
34. Loscher W., Honack D., Fassbender C.P., Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: III. Pentylenetetrazole seizure models. Epilepsy Res 1991, 8:171-189.
35. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 1993, 4:289-312.
36. Powell K.R., Holtzman S.G. Parametric evaluation of the development of sensitization to the effects of morphine on locomotor activity. Drug Alcohol Depend 2001, 62:83-90.
37. Foote F., Gale K. Proconvulsant effect of morphine on seizures induced by pentylenetetrazol in the rat. Eur J Pharmacol 1984, 105:179-184.
38. Vaccarino A.L., Kastin A.J. Endogenous opiates: 1999. Peptides 2000, 21:1975-2034.
39. Longo V.G., Massotti M., Sagratella S. Convulsant drugs and changes in the electrical activity of the brain: an investigation of the effects of opioids on chemoconvulsions. Prog Clin Biol Res 1983, 124:121-127.
40. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990, 347:768-770.
41. Dun N.J., Dun S.L., Wu S.Y., Forstermann U., Schmidt H.H., Tseng L.F. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience 1993, 54:845-857.
42. Xu J.Y., Tseng L.F. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse. J Pharmacol Exp Ther 1995, 274:8-16.
43. Ferreira S.H., Duarte I.D., Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 1991, 201:121-122.
44. Duarte I.D., Ferreira S.H. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 1992, 221:171-174.
45. Stefano G.B., Goumon Y., Bilfinger T.V., Welters I.D., Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog Neurobiol 2000, 60:513-530.
46. Gyires K. The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur J Pharmacol 1994, 255:33-37.
47. Calignano A., Persico P., Mancuso F., Sorrentino L. Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice. Eur J Pharmacol 1993, 231:415-419.
48. Fecho K., Maslonek K.A., Coussons-Read M.E., Dykstra L.A., Lysle D.T. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J Immunol 1994, 152:5845-5852.
49. Stefano G.B., Salzet B., Rialas C.M., et al. Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res 1997, 763:63-68.
50. Manzanedo C., Aguilar M.A., Do Couto B.R., Rodriguez-Arias M., Minarro J. Involvement of nitric oxide synthesis in sensitization to the rewarding effects of morphine. Neurosci Lett 2009, 464:67-70.
51. Zarrindast M.R., Asgari-Afshar A., Sahebgharani M. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents. Behav Pharmacol 2007, 18:177-184.
52. Zarrindast M.R., Askari E., Khalilzadeh A., Nouraei N. Morphine state-dependent learning sensitization and interaction with nitric oxide. Pharmacology 2006, 78:66-71.
53. Atalla A., Kuschinsky K. Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine. J Neural Transm 2006, 113:1-10.